CoQ10 for Chronic Fatigue Syndrome (ME/CFS)

The mitochondrial rationale for CoQ10 in ME/CFS is coherent and small trials of CoQ10 with NADH have shown modest fatigue reductions. The evidence base is too small and too short to promise anything, but it is safe and worth a defined trial.

ME/CFS research has repeatedly found markers of impaired mitochondrial and bioenergetic function, including reduced ATP production capacity in peripheral blood mononuclear cells, raised oxidative stress markers, and — in several studies — reduced plasma CoQ10, with lower levels correlating with worse fatigue and cognitive symptoms. CoQ10 is essential for electron transport chain function and is also the principal lipid-soluble antioxidant in cell membranes. The proposition is that supplementation supports ATP regeneration and reduces the oxidative damage that impairs it further. NADH is frequently combined with it because the two act at adjacent points in the same pathway — NADH as the electron donor at complex I, CoQ10 as the acceptor.

The most relevant trials come from Castro-Marrero and colleagues, who randomised ME/CFS patients to CoQ10 plus NADH or placebo. An eight-week trial reported reduced fatigue impact scores and improved biochemical markers of mitochondrial function; a subsequent longer trial reported improvements in fatigue and, less consistently, sleep and pain. Effect sizes were modest and the samples numbered in the dozens. Observational work supports the biochemical premise: reduced plasma CoQ10 has been documented in ME/CFS cohorts and correlated with symptom severity. What is missing is scale and independence. There is no large multi-centre trial, no long-term follow-up, and no evidence that CoQ10 changes the disease course rather than shifting a fatigue score. Given how many interventions have failed in ME/CFS, and how vulnerable this patient group is to overselling, the honest position is that this is a reasonable low-risk trial rather than a treatment.

People whose fatigue is actually explained by an untreated cause — iron deficiency, hypothyroidism, sleep apnoea, depression — will not respond, and those causes should be excluded first. Those without post-exertional malaise likely do not have ME/CFS and should revisit the diagnosis.